Genentech would use this data to identify Medicaid Managed Care claims that occurred at hospitals (identified by NPI) in the years 2014 through 2017. Genentech will identify package size equivalents (by NDC) that were billed to Medicaid Managed Care programs in Washington State in each quarter. Genentech will compare this dispensing data to its own 340B sales data to the same hospital NPI’s that billed Medicaid Managed Care Programs. The point of the analysis is to identify if these hospitals purchase/dispense patterns were compliant with state 340B guidance, and if the hospital purchase/dispense pattern resulted in 340B duplicate discounts paid by Genentech. At this time, WA State Medicaid Managed Care CLD’s do not provide the treating facility NPI, effectively preventing Genentech from performing even a basic adjudication of these claims before it is required to pay Medicaid Rebates to WA State on them.